Natasha Marrus is a board-certified child and adolescent psychiatrist and associate professor of psychiatry at Washington University School of Medicine in St. Louis. She has more than 10 years of experience in developmental neuroimaging and applying novel phenotyping of autism-relevant behaviors in infancy to quantify their relationship to later autism outcomes.
Natasha Marrus
Associate professor of psychiatry
Washington University School of Medicine in St. Louis
From this contributor
By
Sneha Chaturvedi, John Constantino, Natasha Marrus, Sven Sandin, Benjamin Yip
19 September 2024
6 min read
Autism is more heritable in boys than in girls
If boys have greater inherited liability for autism, the female protective effect may not fully explain the sex difference in prevalence.
Autism is more heritable in boys than in girls
By
Sneha Chaturvedi, John Constantino, Natasha Marrus, Sven Sandin, Benjamin Yip
19 September 2024 | 6 min read
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
By
Lauren Schneider
4 February 2026 | 7 min read
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
By
Claudia López Lloreda
3 February 2026 | 4 min read
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
By
Calli McMurray
3 February 2026 | 5 min read